How is the efficacy of patient selection criteria for adjuvant pembrolizumab after curative surgery of clear cell renal cell carcinoma with intermediate to high risk of recurrence? A real-life data analysis from single institutional experience

Erdem S., Tantekin S. A., Özervarlı M. F., Pazır Y., Hürdoğan Ö., Özlük M. Y., ...More

IURES 2025 Kongresi, Muğla, Turkey, 6 - 09 November 2025, pp.28-30, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• City: Muğla
• Country: Turkey
• Page Numbers: pp.28-30
• Istanbul University Affiliated: Yes